Media
Benzinga Professional
- 12:48 PM Wedbush Downgrades XenoPort, Inc. to Neutral
- 12:48 PM Benzinga Weekly Options Outlook for the Week of May 20
- 12:48 PM Number of Filings from Hayman Capital on Supermedia/Dex Media/Dex One Hitting the EDGAR Site, Hayman Showing 9.7% Stake in Dex Media
- 12:44 PM GM's Mark Reuss Speaking to Reporters in Detroit, Says Seeing Optimism in Auto Market
- 12:33 PM Mid-Day Market Update: Markets Edge Higher, Team Drops On Q4 Earnings Outlook
- 12:28 PM CNBC's Kate Kelly Reporting SAC Capital Not Confirming or Denying Receipt of Subpoena for Steven Cohen
- 12:26 PM UPDATE: Morgan Stanley Raises Price Target On Boyd Gaming on Increased LV Market Estimates/Online-Confidence
- 12:26 PM UPDATE: Aegis Capital Lowers Pernix Therapeutics PT on Reduced Company Guidance
- 12:24 PM UPDATE: Piper Jaffray Raises PT on American Vanguard Following Midwest Farm Tour
- 12:24 PM UPDATE: Benchmark Raises PT on United Online on FTD Spin-Off Plan
- 12:24 PM UPDATE: Oppenheimer Raises PT on BJ's Restaurants Following Management Meetings
- 12:23 PM Thailand ETF Embodies New World Order
- 12:22 PM Moody's Affirms Century Aluminum Ratings; Outlook Lowered to Negative
- 12:21 PM UPDATE: Hayman Capital Showing 0% Stake in Dex Media, Had Shown 5.94% Stake as of March 31st
- 12:20 PM Wedbush Maintains Neutral on Williams-Sonoma, Inc., Raises PT to $50.00
Brain Trust
MORE FROM InvestorsObserver
MORE FROM Michael Prus
- UPDATE: Benchmark Raises PT on United Online on FTD Spin-Off Plan
- UPDATE: Oppenheimer Raises PT on BJ's Restaurants Following Management Meetings
- Thailand ETF Embodies New World Order
- FedEx and Other Logistics Stocks Worth a Look Now
- JP Morgan Chase's Thomas Lee On Undervalued Markets
- UPDATE: Piper Jaffray Raises PT on GT Advanced Technologies Following Thermal Technology Acquisition
- UPDATE: Goldman Sachs Raises PT on EverBank Financial on Multiple Positive Factors
- Here Come Hollywood's Wannabe Summer Blockbusters
- UPDATE: Royalty Pharma Confirms Increased $12.50/Share Cash Bid for Elan
- Microsoft's Third Xbox to be Unveiled in 24 Hours
- The 5 Can't-Miss Apple Stories from the Past Week
- Earnings Expectations for the Week of May 20
- U.S. Steel, Genomic Health and Other Stocks Insiders Are Buying
- Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung Cancer
- Barron's Recap: Cues from Cooperman
- Benzinga's M&A Chatter for Friday May 17, 2013
- Campbell Soup Earnings Preview: Double-Digit Revenue Growth Expected
- Benzinga Market Primer: Monday, May 20
- Can You Think of 9 Companies with Stellar Customer Service?
- Presidential Visit Puts Myanmar Investment Theme in Spotlight